Back to top

Zacks.com featured highlights include include Hasbro, Regeneron Pharmaceuticals, Applied Materials, Vantiv, and CBRE Group

Read MoreHide Full Article

For Immediate Release

Chicago, IL – September 19, 2017 - Stocks in this week’s article include Hasbro, Inc. (Nasdaq: (HAS - Free Report)  – Free Report), Regeneron Pharmaceuticals, Inc. (Nasdaq: (REGN - Free Report)  – Free Report), Applied Materials, Inc. (Nasdaq: (AMAT - Free Report)  – Free Report), Vantiv, Inc. (NYSE: (VNTV - Free Report)  – Free Report) and CBRE Group, Inc. (NYSE: (CBG - Free Report)  – Free Report).

Screen of the Week of Zacks Investment Research:

5 Stocks with Impressive Sales Growth Worth Betting On

In a bullish market, selecting stocks is not an easy task. One might end up with overpriced and unprofitable stocks.

So, while choosing stocks, one should employ a meticulous strategy with focus on low risk stocks that usually provide steady returns. Nonetheless, at times, with an aim to book higher returns, investors apply complex investment strategies, which may not lead to the desired returns.

So, it’s advisable to use conventional strategies, based on key fundamentals, to choose stocks. Not only are such strategies safe, they are valuable in bearish markets as well. One such strategy is focus on sales growth.

Why Sales Growth?

Persistent growth in sales is the key to the survival of any business. For any company, sales growth not only provides an insight into product demand and pricing power, it is vital for growth projections and strategic decision making.

But investors often fail to consider sales growth as a dependable metric. This could be because of investors’ preconceived notion that a company’s stock price is generally sensitive to its earnings momentum.

However, it should be kept in mind that in case companies incurs a loss (albeit temporarily), these are valued on its revenues. Top-line growth (or decline) is generally an indicator of a company’s future earnings performance.

Also, in an improving economy, absence of sales growth indicates that the company’s market share is not increasing. Hence, some sustained sales growth is necessary to support the bottom line.

Therefore, Price-to-Sales (P/S) ratio can turn out to be an appropriate metric for stock valuation. The importance of the metric lies in the fact that management has limited opportunities to manipulate revenues unlike earnings.

Nevertheless, a huge sales number does not always turn into profits. Hence, it’s more sensible to consider a company’s cash position along with its sales number. Substantial cash in hand and a steady cash flow provide a company more flexibility with respect to business decisions and investments.

Picking the Winning Stocks

In order to shortlist stocks that have witnessed impressive sales growth along with a high cash balance, we have selected 5-Year Historical Sales Growth (%) greater than X-Industry and Cash Flow greater than $500 million as our main screening parameters.

But sales growth and cash strength are not the absolute criteria for selecting stocks. So, we added certain other factors to arrive at a winning strategy.

Price-to-Sales (P/S) Ratio less than X-Industry: This metric determines the value placed on each dollar of a company’s revenues. The lower the ratio, the better it is for picking a stock since the investor is paying less for each unit of sales.

% Change F1 Sales Estimate Revisions (4 Weeks) greater than X-Industry: Better-than-industry estimate revision has often been seen to trigger an increase in the stock price.

Operating Margin (Average Last 5 years) greater than 5%: Operating margin measures how much every dollar of a company's sales translates into profits. A high ratio indicates that the company has good cost control and sales are increasing faster than costs, an optimal situation for the company.

Return on Equity (ROE) greater than 5%: This metric will ensure that sales growth is translated into profits and the company is not hoarding cash. A high ROE means the company is spending wisely and is in all likelihood profitable.

Zacks Rank less than or equal to 2: Zacks Rank #1 (Strong Buy) or 2 (Buy) stocks are known to outperform irrespective of the market environment.

Here are five of the 16 stocks that qualified the screening:

Based in Pawtucket, RI, Hasbro, Inc. (Nasdaq: HASFree Report) operates as a play and entertainment company. The company has long-term expected earnings per share (EPS) growth rate of 11.7% and carries a Zacks Rank #2.

Regeneron Pharmaceuticals, Inc. (Nasdaq: REGNFree Report) discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. This Tarrytown, NY-based stock currently has long-term expected EPS growth rate of 21.1% and sports a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.

Applied Materials, Inc. (Nasdaq: AMATFree Report), based in Santa Clara, CA, provides manufacturing equipment, services, and software to the semiconductor, display, and related industries. It has long-term expected EPS growth rate of 17.1% and sports a Zacks Rank #1.

Vantiv, Inc. (NYSE: VNTVFree Report) provides electronic payment processing services to merchants and financial institutions. This Cincinnati, OH-based company has a long-term expected EPS growth rate of 14.5% and a Zacks Rank #2.

Headquartered in Los Angeles, CA, CBRE Group, Inc. (NYSE: CBGFree Report) operates as a commercial real estate services and investment company. The company currently has a long-term expected EPS growth rate of 13% and a Zacks Rank #1.

Get the rest of the stocks on the list and start putting this and other ideas to the test. It can all be done with the Research Wizard stock picking and backtesting software.

The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.

Click here to sign up for a free trial to the Research Wizard today.

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

Disclosure: Performance information for Zacks’ portfolios and strategies are available at: https://www.zacks.com/performance.

Zacks Restaurant Recommendations: In addition to dining at these special places, you can feast on their stock shares. A Zacks Special Report spotlights 5 recent IPOs to watch plus 2 stocks that offer immediate promise in a booming sector. Download it free »

Sign up now for your free trial today and start picking better stocks immediately. And with the backtesting feature, you can test your ideas to see how you can improve your trading in both up markets and down markets. Don’t wait for the market to get better before you decide to do better. Start learning how to be a better trader today: https://at.zacks.com/?id=111

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

About Screen of the Week

Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine.  But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use. Each week, Zacks Profit from the Pros free email newsletter shares a new screening strategy. Learn more about it here https://at.zacks.com/?id=112

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros.  In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time!Click here for your free subscription to Profit from the Pros.

Get the full Report on HAS - FREE

Get the full Report on REGN - FREE

Get the full Report on AMAT - FREE

Get the full Report on VNTV - FREE

Get the full Report on CBG - FREE

Follow us on Twitter:  https://twitter.com/zacksresearch

Join us on Facebook:  https://www.facebook.com/ZacksInvestmentResearch

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Contact: Jim Giaquinto

Company: Zacks.com

Phone: 312-265-9268

Email: pr@zacks.com

Visit: https://www.zacks.com/performance

Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.



More from Zacks Press Releases

You May Like